Evidence map›Paper›PMID 40710098›Full record

ArticleBiosensors2025

The Power of Old Hats: Rediscovering Inosine-EpPCR to Create Starting Libraries for Whole-Cell-SELEX.

Grigory Bolotnikov, Ann-Kathrin Kissmann, Daniel Gruber, Andreas Bellmann, Roger Hasler, Christoph Kleber, Wolfgang Knoll, Frank Rosenau

Abstract read
In one paragraph

Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Grigory BolotnikovInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.
Ann-Kathrin KissmannInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.ORCID 0000-0002-7164-0166
Daniel GruberInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.ORCID 0009-0007-7142-1039
Andreas BellmannInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.
Roger HaslerFaculty of Medicine and Dentistry, Danube Private University, Steiner Landstraße 124, 3500 Krems an der Donau, Austria.ORCID 0000-0002-0883-3053
Christoph KleberFaculty of Medicine and Dentistry, Danube Private University, Steiner Landstraße 124, 3500 Krems an der Donau, Austria.ORCID 0000-0002-1868-4960
Wolfgang KnollFaculty of Medicine and Dentistry, Danube Private University, Steiner Landstraße 124, 3500 Krems an der Donau, Austria.
Frank RosenauInstitute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany.ORCID 0000-0002-9297-6419

Funding

Austrian Research Promotion Agency 915477Deutsche Forschungsgemeinschaft 465229237Gesellschaft für Forschungsförderung (GFF) of Lower Austria FTI22-G-012
6 · The paper itself

Abstract

Shaking off the forgetfulness towards the methodological power of inosine-mediated error-prone PCR (epPCR), this study reintroduces an often-underappreciated method as a considerably powerful approach for generating aptamer libraries from a single decameric ATCG-repeat-oligonucleotide. The aim was to demonstrate that this simple way of creating sequence diversity was suitable for delivering functional starting libraries for a set of ten whole-cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) processes. This epPCR method uses inosine to introduce targeted mutations, avoiding the need for commercial oligo pools or large-scale synthesis. We applied this method to a "universal aptamer" and subjected the three resulting libraries to two rounds of selection against ten diverse targets including probiotic and pathogenic bacteria (Gram-negative and -positive) as well as human cell lines. The enriched aptamers exhibited new binding specificities, demonstrating that the approach supports functional selection. Much like dusting off an old tool and finding it perfectly suited for a modern task, this work shows that revisiting established techniques can address current challenges in aptamer development. Our main finding is that epPCR provides a robust, cost-effective strategy for generating starting libraries and lowers the barrier for initiating successful SELEX campaigns.

Indexed as

InosinePolymerase Chain ReactionSELEX Aptamer TechniqueAptamers, NucleotideGene LibraryHumansAptamers, NucleotideInosinebiosensorsCell-SELEXDNA aptamerpolyclonal library

Identifiers

PMID40710098
PMCPMC12293787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.